![Hurricane Ian is expected to make its second U.S. landfall Friday, warships from U.S., Japan, and South Korea set sail, and a new ALS drug is FDA approved.](https://san.com/wp-content/uploads/2022/09/FeaturedImage_1664541798906-2022-09-30T015216Z_1264851241_RC23RW9XEYXD_RTRMADP_3_STORM-IAN-FLORIDA.jpg?w=1920)
AFTER BRIEFLY DROPPING TO A TROPICAL STORM YESTERDAY — HURRICANE IAN HAS GAINED MOMENTUM AS IT HEADS FOR THE CAROLINAS TODAY.
THE ENTIRETY OF THE SOUTH CAROLINA COAST IS UNDER A HURRICANE WARNING — OFFICIALS ARE FORECASTING A LIFE THREATENING STORM SURGE. 12 DEATHS HAVE BEEN LINKED TO HURRICANE IAN.
AMERICAN — JAPANESE — AND SOUTH KOREAN WARSHIPS TOOK TO THE SEAS TODAY.
THE THREE NATIONS — CONDUCTING THEIR FIRST TRI-LATERAL ANTI-SUBMARINE DRILLS IN FIVE YEARS.
THE DRILLS CAN BE SEEN AS A RESPONSE TO NORTH KOREA — WHO HAS BEEN TESTING SOPHISTICATED MISSILES THAT CAN BE FIRED FROM THEIR NEWLY BUILT SUBMARINES.
THE F-D-A HAS APPROVED THE DRUG RELYVRIO TO TREAT A-L-S — COMMONLY KNOWN AS LOU GEHRIG’S DISEASE.
RELYVRIO IS NOW THE THIRD U-S APPROVED MEDICINE FOR A-L-S.
HOWEVER F-D-A APPROVAL DIDN’T COME WITHOUT CONTROVERSY.
IT WAS BASED ON RESULTS FROM A SINGLE STUDY.
TYPICALLY — THE F-D-A REQUIRES TWO LARGE STUDIES — OR ONE STUDY WITH “VERY PERSUASIVE” RESULTS.
THE FDA HAS ACKNOWLEDGED THE STUDY HAS ITS LIMITATIONS.
BUT SAY THE APPROVAL WAS NECESSARY AS TREATMEANTS FOR A-L-S ARE FEW AND FAR BETWEEN.